VivoSeq
Other

Intensive Care Units

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Intensive Care Units is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

14/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Unknown status3 · 43%
Completed3 · 43%
Terminated1 · 14%

Clinical Trials

Trial Activity

7 trials

Therapeutic Drug Monitoring of Antifungals in Intensive Care Units
Completed·HHospices Civils de Lyon·N/A·NCT04502771·200 enrolled
Optimizing Stress Ulcer Prophylaxis Practices and Reducing Associated Costs in Intensive Care Units: a Nonrandomized Controlled Study
Completed·—·N/A·NCT06586333·196 enrolled
Age of Blood in Children in Pediatric Intensive Care Units
Completed·WWashington University School of Medicine·Phase 3·NCT01977547·1,538 enrolled
How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units
Terminated·VVanderbilt University Medical Center·Phase 1·NCT00826553·6 enrolled
Population Pharmacokinetics and Pharmacodynamics of Beta-lactams of Interest in Adult Patients From Intensive Care Units
Unknown status·UUniversité Catholique de Louvain·N/A·NCT03440216·20 enrolled
Blood Glucose Management in Intensive Care Units
Unknown status·FFrench Society for Intensive Care·N/A·NCT05775770·525 enrolled
Effect of Alpha-lipoic Acid on Biochemical Markers and Important Outcomes in Patients Admitted to Intensive Care Units
Unknown status·—·Phase 3·NCT01888861·80 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)